{
  "Aspirin": {
    "name": "Aspirin",
    "category": "classical_oral_drug",
    "description": "Non-steroidal anti-inflammatory, COX-1/COX-2 inhibitor",
    "known_bcs_class": "I",
    "year_approved": 1899,
    "physicochemical": {
      "smiles": "CC(=O)Oc1ccccc1C(=O)O",
      "mw": 180.16,
      "logp": 1.31,
      "tpsa": 63.6,
      "hbd": 1,
      "hba": 3,
      "rotatable_bonds": 2,
      "aromatic_rings": 1,
      "rings": 1,
      "heavy_atoms": 13,
      "fsp3": 0.111,
      "qed": 0.55,
      "num_atoms": 13,
      "lipinski_violations": 0,
      "lipinski_details": [],
      "lipinski_compliant": true
    },
    "solubility": {
      "log_s": -2.39,
      "solubility_mg_ml": 0.7333,
      "solubility_class": "High"
    },
    "ph_solubility": {
      "ionizable_groups": [
        {
          "group": "carboxylic_acid",
          "pka": 4.2,
          "type": "acid"
        }
      ],
      "ph_solubility": {
        "pH_1.2": -2.39,
        "pH_4.5": -1.91,
        "pH_6.8": 0.21,
        "pH_7.4": 0.81
      }
    },
    "bcs": {
      "bcs_class": "I",
      "high_solubility": true,
      "high_permeability": true,
      "permeability_score": 1.0,
      "formulation_recommendation": "Conventional immediate-release tablet; low development risk"
    },
    "cds": {
      "cds_score": 71.5,
      "cds_category": "Good",
      "dimensions": {
        "druglikeness": {
          "score": 65.2,
          "weight": 0.2
        },
        "metabolic_stability": {
          "score": 60,
          "weight": 0.2
        },
        "safety": {
          "score": 65,
          "weight": 0.25
        },
        "permeability": {
          "score": 90,
          "weight": 0.15
        },
        "physicochemical": {
          "score": 90,
          "weight": 0.2
        }
      }
    },
    "pri": {
      "pri_score": 0.656,
      "pri_category": "Moderate",
      "components": {
        "applicability_domain": {
          "score": 0.773,
          "weight": 0.3
        },
        "ensemble_uncertainty": {
          "score": 0.586,
          "weight": 0.25
        },
        "conformal_prediction": {
          "score": 0.864,
          "weight": 0.2
        },
        "model_performance": {
          "score": 0.42,
          "weight": 0.25
        }
      }
    },
    "ddi": {
      "ddi_risk_score": 0,
      "ddi_risk_category": "Low",
      "substrate_of": [],
      "inhibitor_of": [],
      "victim_drug": false,
      "perpetrator_drug": false,
      "clinical_warnings": []
    },
    "metabolites": {
      "predicted_metabolites": [
        {
          "reaction": "Aromatic hydroxylation",
          "enzymes": "CYP1A2/CYP2C9",
          "priority": 1
        },
        {
          "reaction": "Ester hydrolysis",
          "enzymes": "CES1/CES2",
          "priority": 2
        }
      ],
      "n_metabolic_sites": 2,
      "dili_structural_alerts": [],
      "dili_alert_count": 0
    },
    "aop": {
      "triggered_aops": [],
      "n_aops_triggered": 0,
      "aop_risk_score": 0,
      "aop_risk_category": "Low"
    },
    "bro5": {
      "compound_class": "ro5_compliant",
      "ro5_violations": 0,
      "is_macrocycle": false,
      "max_ring_size": 6,
      "chameleonicity_score": 0.0,
      "bro5_druglikeness_score": 50,
      "is_protac": false,
      "e3_recruiter": null,
      "oral_bioavailability_risk": "Low"
    },
    "comparative": {
      "most_similar": [
        {
          "drug": "Warfarin",
          "tanimoto": 0.245
        },
        {
          "drug": "Acetaminophen",
          "tanimoto": 0.222
        },
        {
          "drug": "Carbamazepine",
          "tanimoto": 0.205
        },
        {
          "drug": "Naproxen",
          "tanimoto": 0.205
        },
        {
          "drug": "Propranolol",
          "tanimoto": 0.204
        }
      ],
      "max_similarity": 0.245,
      "most_similar_drug": "Warfarin"
    }
  },
  "Simvastatin": {
    "name": "Simvastatin",
    "category": "cyp3a4_victim",
    "description": "HMG-CoA reductase inhibitor (statin), CYP3A4 substrate",
    "known_bcs_class": "II",
    "year_approved": 1991,
    "physicochemical": {
      "smiles": "CCC(C)(C)C(=O)OC1CC(O)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21",
      "mw": 420.55,
      "logp": 3.31,
      "tpsa": 93.06,
      "hbd": 2,
      "hba": 6,
      "rotatable_bonds": 6,
      "aromatic_rings": 0,
      "rings": 3,
      "heavy_atoms": 30,
      "fsp3": 0.75,
      "qed": 0.641,
      "num_atoms": 30,
      "lipinski_violations": 0,
      "lipinski_details": [],
      "lipinski_compliant": true
    },
    "solubility": {
      "log_s": -4.14,
      "solubility_mg_ml": 0.0307,
      "solubility_class": "Moderate"
    },
    "ph_solubility": {
      "ionizable_groups": [],
      "ph_solubility": {
        "pH_1.2": -4.14,
        "pH_4.5": -4.14,
        "pH_6.8": -4.14,
        "pH_7.4": -4.14
      }
    },
    "bcs": {
      "bcs_class": "II",
      "high_solubility": false,
      "high_permeability": true,
      "permeability_score": 0.9,
      "formulation_recommendation": "Solubility-enhancing formulation recommended: amorphous solid dispersion (PVP-VA, Soluplus), nanocrystal, or lipid-based system (SEDDS/SMEDDS)"
    },
    "cds": {
      "cds_score": 66.8,
      "cds_category": "Good",
      "dimensions": {
        "druglikeness": {
          "score": 70.3,
          "weight": 0.2
        },
        "metabolic_stability": {
          "score": 50,
          "weight": 0.2
        },
        "safety": {
          "score": 65,
          "weight": 0.25
        },
        "permeability": {
          "score": 72,
          "weight": 0.15
        },
        "physicochemical": {
          "score": 80,
          "weight": 0.2
        }
      }
    },
    "pri": {
      "pri_score": 0.658,
      "pri_category": "Moderate",
      "components": {
        "applicability_domain": {
          "score": 0.74,
          "weight": 0.3
        },
        "ensemble_uncertainty": {
          "score": 0.935,
          "weight": 0.25
        },
        "conformal_prediction": {
          "score": 0.488,
          "weight": 0.2
        },
        "model_performance": {
          "score": 0.42,
          "weight": 0.25
        }
      }
    },
    "ddi": {
      "ddi_risk_score": 30,
      "ddi_risk_category": "Moderate",
      "substrate_of": [
        "CYP3A4"
      ],
      "inhibitor_of": [],
      "victim_drug": true,
      "perpetrator_drug": false,
      "clinical_warnings": [
        "Potential DDI victim via CYP3A4 -- co-administration with strong inhibitors may increase exposure"
      ]
    },
    "metabolites": {
      "predicted_metabolites": [
        {
          "reaction": "Ester hydrolysis",
          "enzymes": "CES1/CES2",
          "priority": 2
        }
      ],
      "n_metabolic_sites": 1,
      "dili_structural_alerts": [],
      "dili_alert_count": 0
    },
    "aop": {
      "triggered_aops": [
        {
          "aop_id": "AOP:34",
          "organ": "Hepatic",
          "mie": "BSEP inhibition",
          "adverse_outcome": "Cholestasis",
          "confidence": 0.425,
          "matching_triggers": [
            "high_logp"
          ]
        },
        {
          "aop_id": "AOP:25",
          "organ": "Hepatic",
          "mie": "Mitochondrial complex inhibition",
          "adverse_outcome": "Drug-induced liver injury",
          "confidence": 0.3,
          "matching_triggers": [
            "high_logp"
          ]
        }
      ],
      "n_aops_triggered": 2,
      "aop_risk_score": 42,
      "aop_risk_category": "Moderate"
    },
    "bro5": {
      "compound_class": "ro5_compliant",
      "ro5_violations": 0,
      "is_macrocycle": false,
      "max_ring_size": 6,
      "chameleonicity_score": 0.1,
      "bro5_druglikeness_score": 50,
      "is_protac": false,
      "e3_recruiter": null,
      "oral_bioavailability_risk": "Low"
    },
    "comparative": {
      "most_similar": [
        {
          "drug": "Pioglitazone",
          "tanimoto": 0.133
        },
        {
          "drug": "Ibuprofen",
          "tanimoto": 0.108
        },
        {
          "drug": "Warfarin",
          "tanimoto": 0.106
        },
        {
          "drug": "Amoxicillin",
          "tanimoto": 0.106
        },
        {
          "drug": "Naproxen",
          "tanimoto": 0.103
        }
      ],
      "max_similarity": 0.133,
      "most_similar_drug": "Pioglitazone"
    }
  },
  "Cyclosporine A": {
    "name": "Cyclosporine A",
    "category": "bro5_macrocycle",
    "description": "Macrocyclic immunosuppressant, beyond Rule-of-5",
    "known_bcs_class": "IV",
    "year_approved": 1983,
    "physicochemical": {
      "smiles": "CCC1NC(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C(O)C(C)CC=CC)N(C)C(=O)C(C(C)C)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)N(C)C(=O)C(C(C)CC)N(C)C(=O)CN(C)C(=O)C(C(C)C)N(C)C1=O",
      "mw": 1159.61,
      "logp": 4.4,
      "tpsa": 249.7,
      "hbd": 4,
      "hba": 11,
      "rotatable_bonds": 16,
      "aromatic_rings": 0,
      "rings": 1,
      "heavy_atoms": 82,
      "fsp3": 0.803,
      "qed": 0.158,
      "num_atoms": 82,
      "lipinski_violations": 2,
      "lipinski_details": [
        "MW=1159.61 > 500",
        "HBA=11 > 10"
      ],
      "lipinski_compliant": false
    },
    "solubility": {
      "log_s": -8.75,
      "solubility_mg_ml": 0.0,
      "solubility_class": "Very Low"
    },
    "ph_solubility": {
      "ionizable_groups": [],
      "ph_solubility": {
        "pH_1.2": -8.75,
        "pH_4.5": -8.75,
        "pH_6.8": -8.75,
        "pH_7.4": -8.75
      }
    },
    "bcs": {
      "bcs_class": "II",
      "high_solubility": false,
      "high_permeability": true,
      "permeability_score": 0.75,
      "formulation_recommendation": "Solubility-enhancing formulation recommended: amorphous solid dispersion (PVP-VA, Soluplus), nanocrystal, or lipid-based system (SEDDS/SMEDDS)"
    },
    "cds": {
      "cds_score": 31.9,
      "cds_category": "Poor",
      "dimensions": {
        "druglikeness": {
          "score": 8.7,
          "weight": 0.2
        },
        "metabolic_stability": {
          "score": 30,
          "weight": 0.2
        },
        "safety": {
          "score": 59,
          "weight": 0.25
        },
        "permeability": {
          "score": 45,
          "weight": 0.15
        },
        "physicochemical": {
          "score": 10,
          "weight": 0.2
        }
      }
    },
    "pri": {
      "pri_score": 0.514,
      "pri_category": "Moderate",
      "components": {
        "applicability_domain": {
          "score": 0.486,
          "weight": 0.3
        },
        "ensemble_uncertainty": {
          "score": 0.509,
          "weight": 0.25
        },
        "conformal_prediction": {
          "score": 0.679,
          "weight": 0.2
        },
        "model_performance": {
          "score": 0.42,
          "weight": 0.25
        }
      }
    },
    "ddi": {
      "ddi_risk_score": 15,
      "ddi_risk_category": "Low",
      "substrate_of": [],
      "inhibitor_of": [],
      "victim_drug": false,
      "perpetrator_drug": false,
      "clinical_warnings": []
    },
    "metabolites": {
      "predicted_metabolites": [
        {
          "reaction": "N-demethylation",
          "enzymes": "CYP3A4/CYP2D6",
          "priority": 1
        },
        {
          "reaction": "N-oxidation",
          "enzymes": "CYP3A4/FMO3",
          "priority": 2
        }
      ],
      "n_metabolic_sites": 2,
      "dili_structural_alerts": [],
      "dili_alert_count": 0
    },
    "aop": {
      "triggered_aops": [
        {
          "aop_id": "AOP:34",
          "organ": "Hepatic",
          "mie": "BSEP inhibition",
          "adverse_outcome": "Cholestasis",
          "confidence": 0.425,
          "matching_triggers": [
            "high_logp"
          ]
        },
        {
          "aop_id": "AOP:25",
          "organ": "Hepatic",
          "mie": "Mitochondrial complex inhibition",
          "adverse_outcome": "Drug-induced liver injury",
          "confidence": 0.3,
          "matching_triggers": [
            "high_logp"
          ]
        }
      ],
      "n_aops_triggered": 2,
      "aop_risk_score": 42,
      "aop_risk_category": "Moderate"
    },
    "bro5": {
      "compound_class": "bro5_large",
      "ro5_violations": 2,
      "is_macrocycle": true,
      "max_ring_size": 30,
      "chameleonicity_score": 0.9,
      "bro5_druglikeness_score": 30,
      "is_protac": false,
      "e3_recruiter": null,
      "oral_bioavailability_risk": "High"
    },
    "comparative": {
      "most_similar": [
        {
          "drug": "Pioglitazone",
          "tanimoto": 0.103
        },
        {
          "drug": "Amoxicillin",
          "tanimoto": 0.091
        },
        {
          "drug": "Ibuprofen",
          "tanimoto": 0.089
        },
        {
          "drug": "Losartan",
          "tanimoto": 0.086
        },
        {
          "drug": "Amlodipine",
          "tanimoto": 0.078
        }
      ],
      "max_similarity": 0.103,
      "most_similar_drug": "Pioglitazone"
    }
  },
  "ARV-110": {
    "name": "ARV-110",
    "category": "protac",
    "description": "PROTAC degrader targeting androgen receptor (Arvinas)",
    "known_bcs_class": "IV",
    "year_approved": null,
    "physicochemical": {
      "smiles": "CC(C)c1cc(NC(=O)COc2ccc(-c3cnc4cc(F)c(OCC5CCN(CC6CC(=O)NC(=O)C6)C5)cc4n3)cc2)ccc1F",
      "mw": 657.72,
      "logp": 5.47,
      "tpsa": 122.75,
      "hbd": 2,
      "hba": 8,
      "rotatable_bonds": 11,
      "aromatic_rings": 4,
      "rings": 6,
      "heavy_atoms": 48,
      "fsp3": 0.361,
      "qed": 0.204,
      "num_atoms": 48,
      "lipinski_violations": 2,
      "lipinski_details": [
        "MW=657.72 > 500",
        "LogP=5.47 > 5"
      ],
      "lipinski_compliant": false
    },
    "solubility": {
      "log_s": -7.13,
      "solubility_mg_ml": 0.0,
      "solubility_class": "Very Low"
    },
    "ph_solubility": {
      "ionizable_groups": [
        {
          "group": "tertiary_amine",
          "pka": 8.0,
          "type": "base"
        },
        {
          "group": "pyridine",
          "pka": 5.2,
          "type": "base"
        }
      ],
      "ph_solubility": {
        "pH_1.2": 3.67,
        "pH_4.5": -2.85,
        "pH_6.8": -5.89,
        "pH_7.4": -6.43
      }
    },
    "bcs": {
      "bcs_class": "II",
      "high_solubility": false,
      "high_permeability": true,
      "permeability_score": 0.75,
      "formulation_recommendation": "Solubility-enhancing formulation recommended: amorphous solid dispersion (PVP-VA, Soluplus), nanocrystal, or lipid-based system (SEDDS/SMEDDS)"
    },
    "cds": {
      "cds_score": 21.2,
      "cds_category": "Poor",
      "dimensions": {
        "druglikeness": {
          "score": 11.2,
          "weight": 0.2
        },
        "metabolic_stability": {
          "score": 5,
          "weight": 0.2
        },
        "safety": {
          "score": 35,
          "weight": 0.25
        },
        "permeability": {
          "score": 55,
          "weight": 0.15
        },
        "physicochemical": {
          "score": 10,
          "weight": 0.2
        }
      }
    },
    "pri": {
      "pri_score": 0.643,
      "pri_category": "Moderate",
      "components": {
        "applicability_domain": {
          "score": 0.618,
          "weight": 0.3
        },
        "ensemble_uncertainty": {
          "score": 0.813,
          "weight": 0.25
        },
        "conformal_prediction": {
          "score": 0.747,
          "weight": 0.2
        },
        "model_performance": {
          "score": 0.42,
          "weight": 0.25
        }
      }
    },
    "ddi": {
      "ddi_risk_score": 35,
      "ddi_risk_category": "Moderate",
      "substrate_of": [],
      "inhibitor_of": [
        "CYP2D6"
      ],
      "victim_drug": false,
      "perpetrator_drug": true,
      "clinical_warnings": [
        "Potential CYP2D6 inhibitor -- may increase exposure of CYP2D6 substrates"
      ]
    },
    "metabolites": {
      "predicted_metabolites": [
        {
          "reaction": "Aromatic hydroxylation",
          "enzymes": "CYP1A2/CYP2C9",
          "priority": 1
        },
        {
          "reaction": "N-oxidation",
          "enzymes": "CYP3A4/FMO3",
          "priority": 2
        }
      ],
      "n_metabolic_sites": 2,
      "dili_structural_alerts": [],
      "dili_alert_count": 0
    },
    "aop": {
      "triggered_aops": [
        {
          "aop_id": "AOP:34",
          "organ": "Hepatic",
          "mie": "BSEP inhibition",
          "adverse_outcome": "Cholestasis",
          "confidence": 0.425,
          "matching_triggers": [
            "high_logp"
          ]
        },
        {
          "aop_id": "AOP:25",
          "organ": "Hepatic",
          "mie": "Mitochondrial complex inhibition",
          "adverse_outcome": "Drug-induced liver injury",
          "confidence": 0.3,
          "matching_triggers": [
            "high_logp"
          ]
        }
      ],
      "n_aops_triggered": 2,
      "aop_risk_score": 42,
      "aop_risk_category": "Moderate"
    },
    "bro5": {
      "compound_class": "bro5_moderate",
      "ro5_violations": 2,
      "is_macrocycle": false,
      "max_ring_size": 6,
      "chameleonicity_score": 0.2,
      "bro5_druglikeness_score": 50,
      "is_protac": true,
      "e3_recruiter": "glutarimide_crbn",
      "protac_assessment": {
        "strengths": [
          "Multiple rings provide structural rigidity"
        ],
        "challenges": []
      },
      "oral_bioavailability_risk": "Moderate"
    },
    "comparative": {
      "most_similar": [
        {
          "drug": "Imatinib",
          "tanimoto": 0.194
        },
        {
          "drug": "Pioglitazone",
          "tanimoto": 0.185
        },
        {
          "drug": "Metoprolol",
          "tanimoto": 0.167
        },
        {
          "drug": "Naproxen",
          "tanimoto": 0.155
        },
        {
          "drug": "Omeprazole",
          "tanimoto": 0.149
        }
      ],
      "max_similarity": 0.194,
      "most_similar_drug": "Imatinib"
    }
  }
}